Login

Healthcare

00:00:00
Per Andersson, Chief Executive Officer at Xspray Pharma
00:00:00
Emerging Drugs For Central Nervous System - Tim Dyer, CEO, Addex Therapeutics Ltd
00:00:00
Life-changing outcomes for patients worldwide - Wayne Paterson, CEO, Admedus Ltd
00:00:00
Advanced Oncotherapy's technology can slash costs of proton therapy cancer treatment - Nicolas Serandour, CEO, Advanced Oncotherapy PLC
00:00:00
AEterna Zentaris Inc is a specialty biopharmaceutical company - Klaus Paulini, PhD President and Chief Executive Officer, Aeterna Zentaris, Inc.
00:00:00
The vast global opportunity for the Maxigesic painkiller - Dr Hartley Atkinson Chief Executive Officer, Executive Director and Co-Founder, AFT Pharmaceuticals Ltd
00:00:00
Medical device, used in patients undergoing breast reconstruction following a mastectomy - Scott Dodson, CEO, AirXpanders Inc.
00:00:00
Taking the opportunity to give an update to the Company's shareholders - Søren Bregenholt CEO, Alligator Bioscience
00:00:00
Inflammation & Antibodies with Ampio Pharmaceutical - Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc
00:00:00
Company's successful listing on the exchange - Joe Wiley, CEO of Amryt Pharma
00:00:00
Christopher U. Missling, PhD, President & CEO of Anavex Life Sciences Corp.
00:00:00
Discusses what is unique about the company and what newsflow investors can expect - Michel Baijot, CEO of Asit Biotech
00:00:00
Avacta Group Plc making 'excellent progress' on lead programmes - Alastair Smith Chief Executive Officer, Avacta Group plc.
00:00:00
Take to the depths of the earth to experience how Bellevue Gold (ASX:BGL) operates - Darren Stralow Managing Director and CEO, Bellevue Gold Ltd
00:00:00
Interview with CEO Jonathan Royce regarding restructuring program -Jonathan Royce Chief Executive Officer, Bio-Works Technologies
00:00:00
Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE Executive Chair, biOasis Technologies Inc

© 2017 - Townhall + Tv